DOUBLE MEDICAL TECHNOLOGY INC. Double Medical Technology Inc. Stock
Equities
002901
CNE1000032W7
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.32 CNY | +1.10% |
|
+1.45% | -27.77% |
| Apr. 30 | Double Medical Technology Inc. Approves the Cash Dividend for the Year 2023 | CI |
| Apr. 29 | Double Medical Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2024 * | 2.02B 278M | Sales 2025 * | 2.58B 356M | Capitalization | 12.14B 1.68B |
|---|---|---|---|---|---|
| Net income 2024 * | 305M 42.12M | Net income 2025 * | 466M 64.35M | EV / Sales 2024 * | 6.02 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.71 x |
| P/E ratio 2024 * |
39.6
x | P/E ratio 2025 * |
26.1
x | Employees | 4,033 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 13.68% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.10% | ||
| 1 week | +1.45% | ||
| 1 month | -8.72% | ||
| 3 months | -2.33% | ||
| 6 months | -27.82% | ||
| Current year | -27.77% |
1 week
28.33
29.58
1 month
28.3333.33
Current year
23.0440.30
1 year
23.0441.38
3 years
23.0480.48
5 years
23.04120.38
10 years
13.87120.38
| Managers | Title | Age | Since |
|---|---|---|---|
Jiong Luo
CEO | Chief Executive Officer | 56 | 11-05-31 |
Dan He Chen
DFI | Director of Finance/CFO | 44 | 23-08-29 |
Zhi Xiong Lin
CHM | Chairman | 51 | 04-07-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Wei Xiao
BRD | Director/Board Member | 59 | 22-10-26 |
Lin Lin
BRD | Director/Board Member | 50 | 19-01-08 |
Zhi Xiong Lin
CHM | Chairman | 51 | 04-07-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 112 M€ | +4.61% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 29.32 | +1.10% | 1,058,100 |
| 24-05-30 | 29 | +0.03% | 774,600 |
| 24-05-29 | 28.99 | +0.24% | 716,220 |
| 24-05-28 | 28.92 | -1.23% | 866,724 |
| 24-05-27 | 29.28 | +1.31% | 1,260,793 |
End-of-day quote Shenzhen S.E., May 30, 2024
More quotes
Double Medical Technology Inc is a China-based company and mainly engaged in manufacture, development and sales of medical precious consumable. The main products of the Company include orthopedic trauma implant materials, spinal implant materials and nerve surgical implant materials. Also, the Company manufactures surgical instruments. The Company distributes its products in domestic and overseas markets.
Calendar
2024-08-20
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
29.32
CNY
Average target price
41
CNY
Spread / Average Target
+39.84%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -27.77% | 1.68B | |
| +13.73% | 130B | |
| -8.17% | 10.99B | |
| -4.33% | 8.35B | |
| +41.80% | 5.67B | |
| -21.94% | 4.72B | |
| +7.81% | 3.42B | |
| -10.26% | 2.76B | |
| -10.29% | 2.11B | |
| -13.58% | 1.92B |
- Stock Market
- Equities
- 002901 Stock
